|
Purpose of This PDQ Summary
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of childhood acute lymphoblastic leukemia (ALL). This summary is reviewed regularly and updated as necessary by the PDQ Pediatric Treatment Editorial Board 1
Information about the following is included in this summary:
- Incidence and risk factors.
- Cellular classification.
- Prognostic variables.
- Treatment options.
- Treatment considerations for certain ALL childhood subgroups.
This summary is intended as a resource to inform and assist clinicians and other health professionals who care for pediatric cancer patients. It does not provide formal guidelines or recommendations for making health care decisions.
In the summary, treatments are described as “standard” or “conventional” and “under clinical evaluation.” These designations should not be used as a basis for reimbursement determinations.
This summary is also available in a patient version 2, which is written in less-technical language, and in Spanish 3. |
